tirzepatide

pipelines in the sun
Biotech

Lilly's next focus: Testing incretins in neuro, immunology fields

“We'll be prepared to move rapidly into phase 3 trials based on clinical data and where our conviction is high,” Lilly's CSO Daniel Skovronsky said.
Gabrielle Masson Feb 6, 2025 2:35pm
Close up of horse legs and hooves running on sand track

Biolexis enters small molecule into oral GLP-1 horse race

Sep 13, 2024 12:24pm
pond lilly pads

Arrowhead dips toes into obesity pond with 2 preclinical assets

Aug 14, 2024 3:50pm
baseball field pitch inning

The most valuable R&D projects? You guessed it: obesity

Jul 11, 2024 5:00am
frozen cold viking long boat winter snow

Viking's MASH drug scores where Madrigal's didn't

Jun 4, 2024 1:51pm
pipeline pipes RD research

A look at the R&D landscape in obesity, led by GLP-1s

Mar 19, 2024 8:00am